SP1 and malignant colon neoplasm: Simultaneously, butyrate also promotes the acetylation of Sp1 and Sp3 in colon cancer HT-29 cells and further upregulates the expression of p53 targets (p21WAF1, p27, and cyclin-dependent kinases), induces cell cycle arrest, and promotes cancer cell apoptosis [149].